TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.

Start Monitoring Your Investments

Investigation On Behalf Of Targanta Therapeutics Corp. (NASDAQ: TARG) Investors Over Potential Breaches Of Fiduciary Duty By The Board Of TARG Announced

To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

On January 12, 2009 the Medicines Company announced to acquire Targanta Therapeutics Corp. (NASDAQ: TARG). According to a press rlease an investigation on behalf of Targanta Therapeutics Corp. (NASDAQ: TARG) investors over potential claims against the Board of Directors of Targanta Therapeutics Corporation concerning possible breaches of fiduciary duty and other violations of state la...

You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Investigation On Behalf Of Targanta Therapeutics Corp. (NASDAQ: TARG) Investors Over Potential Breaches Of Fiduciary Duty By The Board Of TARG Announced

Investigation Overview

@screen width:

@theme:

@breakpoints:

@layout: